Safety and Performance of Novalung ECMO Kit and Xenios 2.0
Part of Lungs & breathing clinical trials.
This study is testing how well a special ECMO device (Novalung ultimate kit with Xenios 2.0) works for adults in the hospital and during ground transport. If you already need ECMO with this specific device, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult (18 or older).
- You are currently on ECMO using Novalung ultimate kit and Xenios 2.0 (and possibly MultiSupport Ground for transport).
- You (or your legal representative or a doctor in an emergency) have signed a consent form.
- You are not in another interventional clinical study that could affect this one.
- You have not taken part in this same study before.
- Your ECMO tubes were placed at a hospital involved in this trial or a referring hospital.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is testing a new device (MiniLung Petite Kit) for babies and young children with severe lung or heart failure. The device helps oxygenate the blood and remove carbon dioxide, giving the lungs and heart a chance to rest and heal.
This trial looks at using a specific heart-lung support machine (the EUROSETS ECMOLIFE system) for adults who need urgent “extra” circulation support. It may help clinicians understand how well the device works in serious situations like shock, cardiac arrest, or after heart surgery.
This platform trial studies which treatment works best for adults with sudden, severe breathing failure needing oxygen or a breathing machine in the ICU. It may help patients by matching them to the most appropriate treatment strategy and tracking outcomes to improve care.
This trial is for people with severe lung failure (ARDS) who are already on a life-support machine called VV-ECMO. It tests whether adding a special breathing tube (CPAP) can help their lungs heal better.
This study looks at how platelets (the cells that help clot blood) behave in patients on a lung-support machine called ECMO. By taking blood samples, researchers hope to better understand clotting issues that can occur during ECMO support.
This study compares two ways of using a heart-lung machine (ECMO) during lung transplant surgery. The goal is to see if using ECMO only when needed works as well as using it for everyone. This could help reduce risks and improve recovery.
Hear when a new Extracorporeal Membrane Oxygenation Complication trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.